2023
DOI: 10.1039/d3md00273j
|View full text |Cite
|
Sign up to set email alerts
|

Development of novel thiazolidine-2,4-dione derivatives as PPAR-γ agonists through design, synthesis, computational docking, MD simulation, and comprehensive in vitro and in vivo evaluation

Mahendra Gowdru Srinivasa,
Revanasiddappa B. C.,
Ashwini Prabhu
et al.

Abstract: The present study was conducted to develop new novel 2,4-thiazolidinedione derivatives (3h–3j) as peroxisome proliferator-activated receptor-γ (PPAR-γ) modulators for antidiabetic activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 36 publications
0
0
0
Order By: Relevance